Platinum Sponsors
Gold Sponsors
Scientific Program
| 08:00-09:00 |
Welcome & Registration | |||||
| 09:00-09:15 | Opening Session Chair: Ms. Hagit Nof |
|||||
| Greetings Dr. Ravit Geva, CTrials Chair Person, Director of the Oncology Research Unit, Sourasky Medical Center, Tel Aviv Ms. Idit Chernovitz, CEO, Pharma Israel  |
||||||
| 09:10-09:30 | Challenges of the Clinical trials Department of the Israeli Ministry of Health. Where Are We Headed? Dr. Catherine Ela, Head of Clinical Trials, MOH |
|||||
| 09:30-09:50 | Big Pharma HQ Insights - How to Improve Your Chances to Participate in Early Phase Oncology Study Dr. Gary Gordon, Vice President, Oncology Development, Abbvie, USA  |
|||||
| 09:50-10:10 |
|
|||||
| 10:10-10:30 |
|
|||||
| 10:30-10:50 | Coffee Break and Exhibition | |||||
| 10:50-11:05 | Prof. Zvi Borochovich, Chairman of the Helsinki Committee for Clinical Trials, Ministry of Health, Israel |
|||||
| 11:05-12:00 | Panel Discussion: "The Patient Will See You Now" Moderator: Dr. Boaz Tadmor, Head of Research Authority, Rabin Medical Center Prof. Arnon Afek, Acting Associate Director General, Ministry of Health Prof.Zvi Borochovich, Chairman of the Helsinki Committee for Clinical Trials, Ministry of Health Dr. Ora Dar, Head of Life Sciences Sector, Office of the Chief Scientist, Ministry of Economy Dr. Avi Livnat, Advisor to the Helsinki Committee, Clalit Health Services Mr. Shlomo Pashkus, Manager of R&D in Higher Education Sector, Budget Division, Ministry of Finance Mr. Uzi Keren, Ministry of Health Dr. Hagai Kedem, Ministry of Health Arie Biton and Sarit Kleinman |
|||||
| 12:00-12:30 | CTrials General Assembly | |||||
| 12:30-12:45 | Coffee Break and Exhibition | |||||
| 12:45-15:00 | The Subject Chair: Dr. Hagai Kedem |
The Regulator Chair: Dr. Moshe Neuman |
The Investigator Chair: Dr. Raanan Berger |
The CRO/ Sponsor Chair: Ms. Tali Zeevi |
||
| 12:45-13:10 |
Pharma 2020 - Digital Health Strategies you need to start now Mr. Joe DustinPrincipal, Mobile Health, Medidata |
Innovations in the GCP Guidelines and Trends in the International Regulation of Clinical Trials Dr. Moshe Neuman |
Cancer Genes Drive To The Clinic Gidi Rechavi |
Is it Still Worth Working for a CRO? Dr. Stefano Marini President, EUCROF, Italy  |
||
| 13:10-13:30 | The Subject's Perspective on Clinical Trials Aryeh Copperman Executive Director, The Pulmonary Hypertension Association |
The Effect of Changes in FDA Regulations for Combination Products and Drug Devices on their Clinical Trial Protocols Mr. Ken Phelps President and CEO, Camargo Pharma, USA |
Clinical Trials in the Era of Genomic Medicine Prof. Tamar Peretz Head, Sharett Institute of Oncology, Director, Center for Malignant Breast Diseases Lawrence Schacht Chair of Oncology,Hadassah University Hospital, Jerusalem, Israel |
Global Trials Execution Ms. Tami Yardeni-Nadiv VP of Global Clinical Operations, Teva, Israel |
||
| 13:30-13:50 |
Logistics of Clinical Trials at the Subject's Home Ms. Victoria Nahary |
Supervision and Monitoring of Clinical Trials Dr. Miriam Cohen-Kandli |
Infected research literature. Integrity is the problem Prof. Jacque Michel |
Intelligent EDC Solutions. Risk Base Monitoring and Safety link Mr. Rohit Mistry VP Business Development Omnicomm, USA |
||
| 13:50-14:10 | TBA |
Clinical Trial Design Q&A Mr. Gil Harari |
TBA |
Clinical Recruitment Management Dr. Barbara Derler Clinical Project Manager, QPS, Austria  |
||
| 14:10-14:30 | The Way to Harmonisation: the Impact of the New European Regulation on Clinical Trials Dr. Irene Fermont Consultant, Pharmacovigilance & Risk Management, Israel |
What medical writing resources are available to Israelis? Mr. Diarmuid De Faoite EMWA, UK  |
Implementing Personalized Cancer Medicine in Clinical Trials: The WINTher Experience Dr. Raanan Berger |
Biotech Supply Chain Challenges & Risk Management Ron Melnik |
||
| 14:30 | Lunch | |||||
